Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease
Journal of Aerosol Medicine and Pulmonary Drug Delivery · 01.08.2024 · 37 (4) · 171-179
DOI: 10.1089/jamp.2023.0045 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Aerosol Medicine and Pulmonary Drug Delivery, online erschienen am 29.05.2024. Verfasst von Roy A Pleasants und 4 weiteren Autor:innen. Beteiligte Einrichtung: Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Bronchodilator Agents, Albuterol, Dry Powder Inhalers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Introduction
Identifying factors influencing peak inspiratory flow (PIF) is essential for aerosol drug delivery in stable patients with chronic obstructive pulmonary disease. While a minimum PIF for dry powder inhalers (DPIs) is established, acute bronchodilator (BD) effects on PIF remain unknown. Materials and Methods: An inspiratory flow meter (In-Check™ DIAL) was used to measure PIF in stable patients during a 24-week observational cross-sectional study. Additionally, bronchodilator responsiveness (BDR) was determined using the In-Check DIAL device and spirometry. Patients received four puffs of albuterol, and pre- and post-BD PIF, forced expiratory volume in one second (FEV 1 ), and forced vital capacity were measured. Sixty-three patients completed acute BDR data collection from July 31, 2019, to November 9, 2021. Primary endpoints were pre- and post-BD spirometry and PIF. Statistical analyses included PIF correlations with FEV 1 . BD change was assessed according to inhaler resistance and sex (subgroup analysis).
Results
Median patient age was 64.8 years, 85.7% were non-Hispanic White, and 57.1% were female. The median increase in absolute PIF (In-Check DIAL) was 5.0 L/min, and the % PIF change was 8.9%. With albuterol, 57.1% experienced a PIF BD change >5.0%, whereas 49.2% experienced a change >10.0%. Similarly, 55.6% experienced an FEV 1 BD change >5.0% and 28.6% had a >10.0% FEV 1 BD change with albuterol. PIF was weakly correlated with FEV 1 BD change (absolute; % PIF; r = 0.28 [ p = 0.02]; r = 0.21 [ p = 0.11]). Pre- and post-BD median PIF were 75.5 and 83.5 L/min for low-to-medium–resistance DPI and 45.0 and 52.0 L/min for high-resistance, respectively. The median increases in pre- and post-BD PIF were 9.0 L/min in males and 4.5 L/min in females. In contrast to when using the In-Check DIAL device, we observed no consistent bronchodilatory effects on PIF measured by spirometry.
Conclusions
Using the In-Check DIAL device, ∼50% of patients experienced >10% PIF increase after acute BD, potentially enhancing medication lung deposition. Further research is required to understand PIF's impact on medication delivery. ClinicalTrials.gov Identifier: NCT04168775
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA.
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.
- Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: Roy A Pleasants
Zitieren
APA
Pleasants, R. A., Shaikh, A., Henderson, A. G., Bayer, V., & Drummond, M. B. (2024). Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 37(4), 171-179. https://doi.org/10.1089/jamp.2023.0045
Vancouver
Pleasants RA, Shaikh A, Henderson AG, Bayer V, Drummond MB. Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2024;37(4):171-179. doi:10.1089/jamp.2023.0045
BibTeX
@article{Pleasants2024,
author = {Pleasants, Roy A and Shaikh, Asif and Henderson, Ashley G and Bayer, Valentina and Drummond, M Bradley},
title = {Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease},
journal = {Journal of Aerosol Medicine and Pulmonary Drug Delivery},
year = {2024},
volume = {37},
number = {4},
pages = {171--179},
doi = {10.1089/jamp.2023.0045}
}
EUVIMED